Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Novel PET Radioligand for Phosphodiesterase-4D (PDE4D)

NCT03861000 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT03861000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03861000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Novel PET Radioligand for Phosphodiesterase-4D (PDE4D)
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 1/2
Overall status
Completed
Start date
March 12, 2019
Completion date
February 11, 2020
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression